TMDX
TransMedics Group, Inc.
Key Financials
Revenue
$605.5M
↑ 37.1%
Net Income
$190.3M
↑ 436.6%
Gross Profit
$362.8M
↑ 38.4%
Operating Income
$108.6M
↑ 189.6%
Total Assets
$1.1B
↑ 32.9%
Cash & Equivalents
$394.8M
↑ 96.2%
Shareholders' Equity
$473.1M
↑ 107.0%
EPS (Diluted)
$4.87
↑ 382.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 3 | 9/29/2026 | View on SEC |
| 4 | 9/14/2026 | View on SEC |
| 8-K | 9/10/2026 | View on SEC |
| 4 | 8/17/2026 | View on SEC |
| 10-Q | 8/4/2026 | View on SEC |
| 8-K | 8/4/2026 | View on SEC |
| 4 | 7/14/2026 | View on SEC |
| 4 | 7/14/2026 | View on SEC |
| 4 | 7/14/2026 | View on SEC |
| 4 | 6/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TMDX |
| Company Name | TransMedics Group, Inc. |
| CIK | 1756262 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | MA |
| Phone | 9785520900 |